Recall of DIMENSION EXL SYSTEM - PHOSPHOROUS (PHOS) ASSAY

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by SIEMENS HEALTHCARE LIMITED.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    54668
  • Event Risk Class
    II
  • Event Initiated Date
    2013-02-14
  • Event Country
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Siemens has confirmed customer complaints of falsely depressed creatinine results when dimension clinical chemistry systems enzymatic creatinine (ezcr) reagent is processed from open wells that are in close proximity to open wells of dimension clinical chemistry systems phosphorus (phos) reagent. both quality control and patient samples may be affected.

Device

  • Model / Serial
    Model Catalog: DF61 (Lot serial: >10 NUMBERS CONTACT MFR); Model Catalog: DF270B (Lot serial: >10 NUMBERS CONTACT MFR)
  • Product Description
    DIMENSION EXL SYSTEM-PHOSPHORUS ASSAY
  • Manufacturer

Manufacturer

  • Manufacturer Address
    OAKVILLE
  • Manufacturer Parent Company (2017)
  • Source
    HC